MicroPort CardioFlow (02160.HK): Board and Management Reshuffle, Chen Guoming Appointed CEO, Brian Chang Takes Chairmanship

NewTimeSpace News: On August 26, 2026, MicroPort CardioFlow (02160.HK) announced that with effect from August 26, 2026, Zhang Ruinian resigned as Chief Executive Officer and was re‑appointed as President of the Company, while remaining as an executive director. Chen Guoming was re‑designated from non‑executive director to executive director and appointed Chief Executive Officer. He also resigned as Chairman of the Board and ceased to be a member of the Audit Committee, and was appointed as a member of the Nomination Committee. Dr. Brian Chang was appointed Chairman of the Board and member of the Audit Committee, and ceased to be a member of the Nomination Committee.

According to the announcement, Mr. Zhang Ruinian has more than 20‑year experience in cardiovascular and medical‑device industry. Mr. Chen Guoming joined the Group in 2016 and possesses over 15‑years of R&D experience in valve‑related medical devices. Dr. Chang has served as a non‑executive director since December 2025 and currently acts as Chief Medical Officer of MicroPort Medical.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.